{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:56:01Z","timestamp":1776851761537,"version":"3.51.2"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000473"],"award-info":[{"award-number":["32000473"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2020C100"],"award-info":[{"award-number":["LH2020C100"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harbin Medical University Scientific Research Innovation Fund","award":["2019-KYYWF-0394"],"award-info":[{"award-number":["2019-KYYWF-0394"]}]},{"name":"Heilongjiang Postdoctoral Research Startup Foundation","award":["LBH-Q19118"],"award-info":[{"award-number":["LBH-Q19118"]}]},{"name":"Innovative Research Program for Graduates of Harbin Medical University","award":["YJSKYCX2019-91HYD"],"award-info":[{"award-number":["YJSKYCX2019-91HYD"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Breast cancer is one of the most common types of cancers and the leading cause of death from malignancy among women worldwide. Tumor-infiltrating lymphocytes are a source of important prognostic biomarkers for breast cancer patients. In this study, based on the tumor-infiltrating lymphocytes in the tumor immune microenvironment, a risk score prognostic model was developed in the training cohort for risk stratification and prognosis prediction in breast cancer patients. The prognostic value of this risk score prognostic model was also verified in the two testing cohorts and the TCGA pan cancer cohort. Nomograms were also established in the training and testing cohorts to validate the clinical use of this model. Relationships between the risk score, intrinsic molecular subtypes, immune checkpoints, tumor-infiltrating immune cell abundances and the response to chemotherapy and immunotherapy were also evaluated. Based on these results, we can conclude that this risk score model could serve as a robust prognostic biomarker, provide therapeutic benefits for the development of novel chemotherapy and immunotherapy, and may be helpful for clinical decision making in breast cancer patients.<\/jats:p>","DOI":"10.1093\/bib\/bbaa311","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T19:13:30Z","timestamp":1602702810000},"source":"Crossref","is-referenced-by-count":80,"title":["Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer"],"prefix":"10.1093","volume":"22","author":[{"given":"Shiyuan","family":"Wang","sequence":"first","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiang","family":"Xiong","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongqing","family":"Su","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlu","family":"Yu","sequence":"additional","affiliation":[{"name":"Public Health College, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[{"name":"Public Health College, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianzi","family":"Lu","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-7835","authenticated-orcid":false,"given":"Yongchun","family":"Zuo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, College of Life Sciences, Inner Mongolia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"2021072117020494200_ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2021072117020494200_ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2021072117020494200_ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2021072117020494200_ref4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"2021072117020494200_ref5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/CCO.0000000000000234","article-title":"Prognostic and predictive immune gene signatures in breast cancer","volume":"27","author":"Bedognetti","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"2021072117020494200_ref6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"2021072117020494200_ref7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","article-title":"Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial","volume":"25","author":"Loi","year":"2014","journal-title":"Ann Oncol"},{"key":"2021072117020494200_ref8","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"2021072117020494200_ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.breast.2017.03.010","article-title":"Tumor infiltrating lymphocytes in early breast cancer","volume":"37","author":"Pruneri","year":"2018","journal-title":"Breast"},{"key":"2021072117020494200_ref10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002194","article-title":"Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study","volume":"13","author":"Ali","year":"2016","journal-title":"PLoS Med"},{"key":"2021072117020494200_ref11","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4832-5","article-title":"The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer"},{"key":"2021072117020494200_ref12","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","article-title":"Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199","volume":"32","author":"Adams","year":"2014","journal-title":"J Clin Oncol"},{"key":"2021072117020494200_ref13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J Immunother Cancer"},{"key":"2021072117020494200_ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc B"},{"key":"2021072117020494200_ref15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bimj.200900028","article-title":"L1 penalized estimation in the cox proportional hazards model","volume":"52","author":"Goeman","year":"2010","journal-title":"Biom J"},{"key":"2021072117020494200_ref16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"2021072117020494200_ref17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"2021072117020494200_ref18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccr.2006.10.009","article-title":"Genomic and transcriptional aberrations linked to breast cancer pathophysiologies","volume":"10","author":"Chin","year":"2006","journal-title":"Cancer Cell"},{"key":"2021072117020494200_ref19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"2021072117020494200_ref20","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"S\u00f8rlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021072117020494200_ref21","article-title":"Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer","volume":"bbaa026","author":"Wang","year":"2020","journal-title":"Brief Bioinform"},{"key":"2021072117020494200_ref22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"2021072117020494200_ref23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2021072117020494200_ref24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy-analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2021072117020494200_ref25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"2021072117020494200_ref26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"2021072117020494200_ref27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088309","article-title":"Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity","volume":"9","author":"Wolf","year":"2014","journal-title":"PLoS One"},{"key":"2021072117020494200_ref28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol Res"},{"key":"2021072117020494200_ref29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv Sci"},{"key":"2021072117020494200_ref30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"2021072117020494200_ref31","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2326-6066.CIR-18-0342","article-title":"Immune cell gene signatures for profiling the microenvironment of solid tumors","volume":"6","author":"Nirmal","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"2021072117020494200_ref32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2021072117020494200_ref33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"2021072117020494200_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"2021072117020494200_ref35","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"2021072117020494200_ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney Michael","year":"2015","journal-title":"Cell"},{"key":"2021072117020494200_ref37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2021072117020494200_ref38","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2021072117020494200_ref39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","article-title":"Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer","volume":"32","author":"Gendoo","year":"2015","journal-title":"Bioinformatics"},{"key":"2021072117020494200_ref40","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"2021072117020494200_ref41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPIXUYDVZ0RZ3G","article-title":"Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab","volume":"144","author":"Lee","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"2021072117020494200_ref42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10549-013-2581-3","article-title":"The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer","volume":"139","author":"Muenst","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2021072117020494200_ref43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"2021072117020494200_ref44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/intimm\/dxw014","article-title":"Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment","volume":"28","author":"Spranger","year":"2016","journal-title":"Int Immunol"},{"key":"2021072117020494200_ref45","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8\u03b1+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J Exp Med"},{"key":"2021072117020494200_ref46","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"2021072117020494200_ref47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"2021072117020494200_ref48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"2021072117020494200_ref49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"2021072117020494200_ref50","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"2021072117020494200_ref51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41590-018-0290-0","article-title":"Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle","volume":"20","author":"Cheng","year":"2019","journal-title":"Nat Immunol"},{"key":"2021072117020494200_ref52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021072117020494200_ref53","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1038\/s41467-019-13329-5","article-title":"An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment","volume":"10","author":"Tekpli","year":"2019","journal-title":"Nat Commun"},{"key":"2021072117020494200_ref54","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1200\/JCO.2012.46.1558","article-title":"Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy","volume":"31","author":"Dowsett","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021072117020494200_ref55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"2021072117020494200_ref56","first-page":"1","article-title":"XGBoost model for chronic kidney disease diagnosis","author":"Ogunleye","year":"2019","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"2021072117020494200_ref57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1109\/TNB.2018.2842219","article-title":"XGBFEMF: an XGBoost-based framework for essential protein prediction","volume":"17","author":"Zhong","year":"2018","journal-title":"IEEE T Nanobiosci"},{"key":"2021072117020494200_ref58","first-page":"247","article-title":"Breast cancer immunotherapy","volume":"1","author":"Zhou","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"2021072117020494200_ref59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2021072117020494200_ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00135","article-title":"Clinical value of RNA sequencing\u2013based classifiers for prediction of the five conventional breast cancer biomarkers: a report from the population-based multicenter Sweden cancerome analysis network-breast initiative","author":"Brueffer","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"2021072117020494200_ref61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/bjc.2017.446","article-title":"Immune gene expression and response to chemotherapy in advanced breast cancer","volume":"118","author":"Foukakis","year":"2018","journal-title":"Br J Cancer"},{"key":"2021072117020494200_ref62","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-018-0945-7","article-title":"Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy","volume":"20","author":"Weiss","year":"2018","journal-title":"Breast Cancer Res"},{"key":"2021072117020494200_ref63","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/4\/bbaa311\/39136731\/bbaa311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/4\/bbaa311\/39136731\/bbaa311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T22:35:29Z","timestamp":1723761329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbaa311\/6030109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa311","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7]]},"published":{"date-parts":[[2020,12,11]]},"article-number":"bbaa311"}}